Key result
Higher atherogenic index of plasma linked to ~60% greater stroke risk across BP strata.
Why the study?
The study investigated the association between the atherogenic index of plasma and stroke risk across blood pressure strata, alongside the mediating roles of BMI and AIP.
Does a higher atherogenic index of plasma (AIP) increase stroke risk across blood pressure strata in Chinese adults?
Cohort (n=8,695)
Yes
Does a higher atherogenic index of plasma (AIP) increase stroke risk across blood pressure strata in Chinese adults?
Higher atherogenic index of plasma is an independent risk factor for stroke across blood pressure strata, with BMI partially mediating this effect.
Higher AIP was associated with stroke risk in high-normal BP; hypothesis-generating for AIP as target, pending trials.
This study investigated the association between the atherogenic index of plasma (AIP) and stroke risk across blood pressure (BP) strata, with exploratory assessments of the bidirectional mediating roles of body mass index (BMI) and AIP. We included 8,695 participants from the China Health and Retirement Longitudinal Study (CHARLS, 2011–2020). AIP was calculated as log₁₀(TG/HDL-C). Time-dependent Cox models were used to estimate the hazard ratios (HRs). Restricted cubic spline (RCS) and mediation analyses were performed. Higher AIP was independently associated with increased stroke risk (HR: 1.60, 95% CI 1.22‑2.09).This association was observed in both the high-normal BP (HR: 2.08, 95% CI 1.21‑3.59) and hypertension strata (HR: 1.47, 95% CI 1.03‑2.11), with no significant interaction by BP strata ( P = 0.660). RCS analysis showed a dose-response relationship between baseline AIP levels and stroke risk across all participants, high-normal BP, and hypertension strata. Exploratory mediation analysis suggested that BMI mediated 20.59% of AIP’s effect on stroke, while AIP mediated 20.52% of BMI’s effect. AIP is an independent risk factor for stroke, with no significant effect modification by BP strata. Exploratory mediation analyses suggest that integrating AIP screening with BMI management could be beneficial for stroke prevention, a finding that requires prospective validation.
No takes yet. Share an insight, caveat, or question.
Feng et al. (2026) conducted a cohort in Stroke (n=8,695). Atherogenic index of plasma (AIP) vs. Lower AIP levels was evaluated on Incident first-ever stroke (HR 1.60, 95% CI 1.22-2.09, p=<0.001). Higher baseline atherogenic index of plasma was independently associated with an increased risk of incident stroke (HR 1.60), with a dose-response relationship observed across blood pressure strata.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: